Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen

References

• Dreyfuss G, Matunis MJ, Pinol-Roma S, Burd CG. hnRNP proteins and the biogenesis of mRNA. Annu Rev Biochem 1993; 62: 289–321
   PubMed Web of Science ®Google Scholar
• Kramer A. The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu Rev Biochem 1996; 65: 367–409
   PubMed Web of Science ®Google Scholar
• Will CL, Luhrmann R. Spliceosomal UsnRNP biogenesis, structure and function. Curr Opin Cell Biol 2001; 13: 290–301
   PubMed Web of Science ®Google Scholar
• Krecic AM, Swanson MS. hnRNP complexes: Composition, structure and function. Curr Opin Cell Biol 1999; 11: 363–371
   PubMed Web of Science ®Google Scholar
• Dreyfuss G, Kim VN, Kataoka N. Messenger-RNA-binding proteins and the messages they carry. Nat Rev 2002; 3: 195–205
   Google Scholar
• Ford LP, Wright WE, Shay JW. A model for heterogeneous nuclear ribonucleoproteins in telomere and telomerase regulation. Oncogene 2002; 21: 580–583
   PubMed Web of Science ®Google Scholar
• Biggiogera M, Bottone MG, Martin TE, Uchiumi T, Pellicciari C. Still immunodetectable nuclear RNPs are extruded from the cytoplasm of spontaneously apoptotic thymocytes. Exp Cell Res 1997; 234: 512–520
   PubMedGoogle Scholar
• Patry C, Lemieux B, Wellinger RJ, Chabot B. Targeting heterogeneous nuclear ribonucleoparticule A1 and A2 proteins by RNA interference promotes cell death in transformed but not in normal mouse cell lines. Mol Cancer Ther 2004; 3: 1193–1199, 1997
   PubMedGoogle Scholar
• Van Venrooij WJ, Sillekens PTG. Small nuclear RNA associated proteins: Autoantigens in connective tissue diseases. Clin Exp Rheumatol 1989; 7: 635–645
   PubMedGoogle Scholar
• Caporali R, Bugatti S, Bruschi E, Cavagna L, Montecucco C. Autoantibodies to heterogeneous nuclear ribonucleoproteins. Autoimmunity 2005; 38: 25–32
   PubMed Web of Science ®Google Scholar
• Plomaritoglou A, Choli-Papadopoulou T, Guialis A. Molecular characterization of a murine, major A/B-type hnRNP protein: mBx. Biochim Biophys Acta 2000; 1490: 54–62
   PubMedGoogle Scholar
• Ma ASW, Moran-Jones K, Shan J, Munro TP, Snee MJ, Hoek KS, Smith R. Heterogeneous nuclear ribonucleoprotein A3, a novel RNA trafficking response element-binding protein. J Biol Chem 2002; 227: 18010–18020
   Google Scholar
• Dangli A, Guialis A, Vretou E, Sekeris CE. Autoantibodies to the core proteins of hnRNPs. FEBS Lett 1988; 231: 118–124
   PubMedGoogle Scholar
• Dangli A, Plomaritoglou A, Boutou E, Vassiliadou N, Moutsopoulos HM, Guialis A. Recognition of subsets of the mammalian A/B type core hnRNP polypeptides by novel autoantibodies. Biochem J 1996; 320: 761–767
   PubMedGoogle Scholar
• Hassfeld W, Steiner G, Studnicka-Benke A, Skriner K, Graninger W, Fischer I, Smolen JS. Autoimmune response to the spliceosome. An immunological link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus. Arthritis Rheum 1995; 38: 777–785
   PubMed Web of Science ®Google Scholar
• O'Farell PZ, Goodman HM, O'Farell PH. High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell 1977; 12: 1133–1142
   PubMedGoogle Scholar
• Guialis A, Patrinou-Georgoula M, Tsifetaki N, Aidinis V, Sekeris CE, Moutsopoulos HM. Anti-5S RNA/protein (RNP) antibody levels correlate with disease activity in a patient with systemic lupus erythematosus (SLE) nephritis. Clin Exp Immunol 1994; 95: 385–389
   PubMedGoogle Scholar
• Cleveland DW, Fischer SG, Kirschner MW, Laemmli UK. Peptide mapping by limited proteolysis in sodium dodecyl sulphate and analysis by gel electrophoresis. J Biol Chem 1977; 252: 1102–1106
   PubMed Web of Science ®Google Scholar
• Guialis A, Jockers-Wretou E, Sekeris CE. Structural relationship of the heterogeneous nuclear ribonucleoprotein core polypeptides from rat liver nuclei. Arch Biochem Biophys 1986; 247: 355–364
   PubMedGoogle Scholar
• Steiner G, Skriner K, Smolen JS. Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: Novel tools for the diagnosis of rheumatic diseases. Int Arch Allergy Immunol 1996; 111: 314–319
   PubMedGoogle Scholar
• Skriner K, Sommergruber WH, Tremmel V, Fischer I, Barta A, Smolen JS, Steiner G. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus and mixed connective tissue disease. J Clin Invest 1997; 100: 127–135
   PubMedGoogle Scholar
• Pinol-Roma S, Choi YD, Matunis MJ, Dreyfuss G. Imunopurification of heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA binding proteins. Genes Dev 1988; 2: 215–227
   PubMed Web of Science ®Google Scholar
• Jensen L, Kuff EL, Wilson SH, Steinberg AD, Klinman DM. Antibodies from patients and mice with autoimmune diseases react with recombinant hnRNP core protein A1. J Autoimmun 1988; 1: 73–83
   PubMedGoogle Scholar
• Astaldi Ricotti GC, Bestagno M, Cerino A, Negri C, Caporali R, Cobianchi F, et al. Antibodies to hnRNP core protein A1 in connective tissue diseases. J Cell Biochem 1989; 40: 43–47
   PubMedGoogle Scholar
• Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, Smolen JS, Steiner G. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 2005; 64: 1731–1736
   PubMed Web of Science ®Google Scholar
• Al-Attia HM, George S. Characterization of systemic lupus erythematosus in patients in UAE. Clin Rheumatol 1995; 14: 171–175
   PubMedGoogle Scholar
• Ho KT, Reveille JD. The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 2003; 5: 80–93
   PubMed Web of Science ®Google Scholar
• Buvoli M, Cobianchi F, Bestagno MG, Mangiarotti A, Bassi MT, Biamonti G, Riva S. Alternative splicing in the human gene for the core protein A1 generates another hnRNP protein. EMBO J 1990; 9: 1229–1235
   PubMedGoogle Scholar
• Kamma H, Horiguchi H, Wan L, Matsui M, Fujiwara M, Fujimoto M, Yazawa T, Dreyfuss G. Molecular characterization of the hnRNP A2/B1 proteins: Tissue-specific expression and novel isoforms. Exp Cell Res 1999; 246: 399–411
   PubMed Web of Science ®Google Scholar
• Zimmermann C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS. The concurrence of rheumatoid arthritis and limited systemic sclerosis. Arthritis Rheum 1998; 41: 1938–1945
   PubMedGoogle Scholar
• Stanek D, Vencovsky J, Kafkiva J, Raska I. Heterogeneous nuclear RNP C1 and C2 core proteins are targets for an autoantibody found in the serum of a patient with systemic sclerosis and psoriatic arthritis. Arthritis Rheum 1997; 40: 2172–2177
   PubMedGoogle Scholar
• Montecucco C, Caporali R, Cobianchi F, Biamonti G. Identification of autoantigens to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis. Arthritis Rheum 1996; 39: 1669–1676
   PubMedGoogle Scholar
• Deshmukh US, Gaskin F, Lewis JE, Kannapell CC, Fu SM. Mechanisms of autoantibody diversification to SLE-related autoantigens. Ann N Y Acad Sci 2003; 987: 91–98
   PubMed Web of Science ®Google Scholar
• Pal R, Deshmukh US, Ohyama Y, Fank Q, Kannapell CC, Gaskin F, Fu SM. Evidence for multiple shared antigenic determinants within Ro60 and other lupus-related ribonucleoprotein autoantigens in human autoimmune responses. J Immunol 2005; 175: 7669–7677
   PubMed Web of Science ®Google Scholar
• Farris AD, Keech CL, Gordon TP, McCluskey J. Epitope mimics and determinant spreading: Pathways to autoimmunity. Cell Mol Life Sci 2000; 57: 569–578
   PubMedGoogle Scholar
• Steiner G, Shovman O, Skriner K, Gilburd B, Langevitz P, Miholits M, Hoet R, Levy Y, Zandman-Goddard G, Hoefler E, Smolen JS, Shoenfeld Y. Induction of anti-RA33 hnRNP autoantibodies and transient spread to U1-A snRNP complex of spliceosome by idiotypic manipulation with anti-RA33 antibody preparation in mice. Clin Exp Rheumatol 2002; 20: 517–524
   PubMedGoogle Scholar
• Heegaard NH, Larsen MR, Muncrief T, Wiik A, Roepstorff P. Heterogeneous nuclear ribonucleoproteins C1/C2 identified as autoantigens by biochemical and mass spectrometric methods. Arthritis Res 2000; 2: 407–414
   PubMedGoogle Scholar
• Hassfeld W, Chan EK, Mathison MD, Portman D, Dreyfuss G, Steiner G, et al. Molecular definition of heterogeneous nuclear ribonucleoprotein R (hnRNP R) using autoimmune antibody: Immunological relationship with hnRNP P. Nucleic Acids Res 1998; 26: 439–445
   PubMedGoogle Scholar
• Rosen A, Casciola-Rosen L. Autoantibodies as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 1999; 6: 6–12
   PubMed Web of Science ®Google Scholar
• Radic MZ, Shah K, Zhang W, Lu Q, Lemke G, Hilliard GM. Heterogeneous nuclear ribonucleoprotein P2 is an autoantigen target in mice deficient for Mer, Axl, and Tyro3 receptor tyrosine kinases. J Immunol 2006; 1: 68–74
   Google Scholar
• Greidinger EL, Gazitt T, Jaimes KF, Hoffman RW. Human T cell clones specific for heterogeneous nuclear ribonucleoprotein A2 autoantigen from connective tissue disease patients assist in autoantibody production. Arthritis Rheum 2004; 50: 2216–2222
   PubMedGoogle Scholar
• Levin MC, Lee SM, Kalume F, Morcos Y, Dohan FC, Hasty KA, Callaway JC, Zunt J, Desiderio DM, Stuart JM. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med 2002; 8: 509–513
   PubMed Web of Science ®Google Scholar